Complete remission of Hodgkin Lymphoma after a concurrent infection with COVID-19: systematic review and meta-analysis
Through December 2019, novel coronavirus (SARS-CoV-2) pneumonia (COVID-19) was reported in Wuhan and has since rapidly spread throughout China. Hodgkin lymphoma represents a heterogeneous hematological malignancy, which is characterized by immunosuppression. There are no clearly defined risk factors...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Al Muthanna University
2022-09-01
|
| Series: | Muthanna Medical Journal |
| Subjects: | |
| Online Access: | https://muthmj.mu.edu.iq/wp-content/uploads/2022/07/Complete-remission-of-Hodgkin-Lymphoma-after-a-concurrent-infection-with-COVID-19-systematic-review-and-meta-analysis.pdf |